NTLA Overview
Upcoming Projects (NTLA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (NTLA)
-
CRISPR Overview: An In-depth Conversation on Potential of the Technology and Likely First Areas of Therapeutic Impact
Tickers: EDIT, Ers Genomics, Caribou, NTLA, CRSP
Executed On: Dec 19, 2016 at 01:00 PM EST
Upcoming & Overdue Catalysts (NTLA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (NTLA)
-
NTLA in vivo Hepatitis B Virus (HBV) program by Intellia, based on CRISPR/Cas9 genetic editing system, set for HBV animal trials in 2017
Tickers: NTLA, BAYRY, CRSP
Occurred on: May 01, 2018 -
Intellia (NTLA) Granted European Patent Covering CRISPR/Cas9 Genome Editing Technology
Ticker: NTLA
Occurred on: Apr 11, 2017 -
Intellia Therapeutics Announces Pricing of Initial Public Offering
Ticker: NTLA
Occurred on: May 05, 2016
Strategic Initiatives (NTLA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
